| Upcoming events on IONIS PHARMACEUTICALS, INC. |
|
| 03/02/21 | | Jahr 2020 Ergebnisveröffentlichung (geplant) |
| 05/11/21 | | Q1 2021 Ergebnisveröffentlichung (geplant) |
| 08/10/21 | | Erstes Halbjahr 2021 Ergebnisveröffentlichung (geplant) |
| 11/10/21 | | Q3 2021 Ergebnisveröffentlichung (geplant) |
|
| Past events on IONIS PHARMACEUTICALS, INC. |
|
| 01/12/21 | 09:40pm | | JP Morgan Healthcare Conference |
| 12/08/20 | 09:00pm | | BMO Capital Markets Boston Growth Conference |
| 12/07/20 | 05:00pm | | Investor Day |
| 12/03/20 | 06:00am | | Piper Sandler Health Care Conference |
|
| Upcoming sector events for IONIS PHARMACEUTICALS, INC. |
|
|
| |
|
| Past sector events for IONIS PHARMACEUTICALS, INC. |
|
|
|
|
|
| Annual results | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 (e) |
Sales
M $ |
Released
Forecast
Spread | 284
282
0,74% | 347
286
21% | 508
457
11% | 600
569
5,3% | 1 123
1 029
9,2% |
710
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread | -68,8
-38,3
-80% | -37,3
-35,8
-4,3% | 75,8
123
-39% | -52,5
-75,0
30% | 378
267
42% |
-93,8
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | -75,8
-62,6
-21% | -46,3
-92,6
50% | 24,5
45,5
-46% | -61,4
-91,6
33% | 366
286
28% |
-111
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | -87,9
-75,2
-17% | -83,6
-133
37% | -23,3
-30,4
23% | -76,2
-104
27% | 347
281
24% |
-105
|
Net income
M $ |
Released
Forecast
Spread | -88,3
-76,6
-15% | -86,6
-128
32% | -5,97
-26,4
77% | 274
-56,3
586% | 294
258
14% |
-74,6
|
EPS
$ |
Released
Forecast
Spread | -0,74
-0,66
-13% | -0,72
-1,05
31% | -0,05
-0,09
46% | 2,07
-0,42
598% | 2,08
1,77
17% |
-0,51
| | Announcement Date | 02/25/2016 | 02/28/2017 | 02/27/2018 | 02/27/2019 | 02/26/2020 | |
|
|
|
| Quarterly results | 2018 Q2 | 2018 Q3 | 2018 Q4 | 2019 Q1 | 2019 Q2 | 2019 Q3 | 2019 Q4 | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 (e) | 2021 Q1 (e) | 2021 Q2 (e) | 2021 Q3 (e) | 2021 Q4 (e) |
Sales
M $ |
Released
Forecast
Spread | 118
130
-9,7% | 145
147
-0,94% | 192
160
20% | 297
285
4,1% | 164
145
13% | 168
152
10% | 494
407
21% | 133
162
-18% | 146
149
-1,9% | 160
182
-12% |
272
|
177
|
181
|
202
|
224
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread |
|
| 13,4
-36,0
137% | 125
111
12% | -15,3
-32,0
52% | 5,62
-52,0
111% | 264
192
37% | -57,9
-23,6
-145% | -48,1
-55,6
13% | -32,7
-16,4
-99% |
47,0
|
|
|
|
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | -50,3
-24,1
-108% | -18,6
-30,0
38% | 10,8
-20,2
153% | 121
104
16% | -19,0
-52,8
64% | 3,00
-52,7
106% | 261
198
32% | -61,0
-31,6
-93% | -52,0
-47,3
-9,9% | -37,0
-25,8
-43% |
39,6
|
-23,9
|
-17,9
|
-11,0
|
-17,9
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | -56,2
-39,0
-44% | -19,9
-43,4
54% | 10,8
-35,9
130% | 121
103
17% | -17,0
-53,6
68% | 4,00
-52,0
108% | 238
190
25% | -62,0
-30,1
-106% | -44,0
-46,3
4,9% | -40,0
-20,0
-100% |
35,5
|
-30,5
|
-23,8
|
-17,8
|
-21,4
|
Net income
M $ |
Released
Forecast
Spread | -40,4
-28,6
-41% | -4,56
-27,4
83% | 320
-9,42
3 499% | 84,0
99,0
-15% | -1,00
-38,7
97% | 26,0
-41,2
163% | 184
165
12% | -48,0
-23,4
-106% | -32,0
-33,7
5,2% | -31,0
-10,3
-202% |
37,7
|
-24,8
|
-16,3
|
-11,2
|
-15,4
|
EPS
$ |
Released
Forecast
Spread | -0,29
-0,10
-187% | -0,03
-0,17
83% | 2,21
-0,04
5 025% | 0,62
0,74
-16% | -0,01
-0,27
96% | 0,18
-0,30
159% | 1,28
1,00
28% | -0,35
-0,12
-180% | -0,23
-0,26
10% | -0,22
-0,10
-125% |
0,26
|
-0,30
|
-0,31
|
-0,22
|
-0,11
| | Announcement Date | 08/07/2018 | 11/06/2018 | 02/27/2019 | 05/09/2019 | 08/07/2019 | 11/06/2019 | 02/26/2020 | 05/06/2020 | 08/05/2020 | 11/04/2020 | | | | | |
|
Financial data source
© 2021 S&P Global Market Intelligence
|
|
© 2021 Factset
|
|
|
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
Previous period
